Emmanuel Adu Gyamfi, Ph.D.
About Emmanuel Adu Gyamfi, Ph.D.
Emmanuel Adu Gyamfi, Ph.D., is the Director of Global Regulatory CMC (Gene & Cell Therapy) at Bristol Myers Squibb, with a background in biochemistry, molecular virology, and regulatory affairs.
Current Position at Bristol Myers Squibb
Emmanuel Adu Gyamfi, Ph.D., currently serves as the Director of Global Regulatory CMC (Gene & Cell Therapy) at Bristol Myers Squibb in the United States. In this role, he focuses on developing global regulatory strategies for gene and cell therapies. His work involves supporting the acceleration of next-generation therapies, addressing regulatory challenges, and shaping policy developments in this field.
Experience at the FDA
Emmanuel Adu Gyamfi worked at the FDA as a CMC Reviewer for Gene & Cell Therapy from 2019 to 2023. During his four-year tenure, he was responsible for reviewing and evaluating regulatory submissions to ensure compliance with federal guidelines and standards. His work at the FDA provided him with invaluable insights into regulatory affairs, further enhancing his expertise in gene and cell therapies.
Previous Role at Pfizer
From 2017 to 2019, Emmanuel Adu Gyamfi was employed at Pfizer as a Senior Scientist in the Gene & Cell Therapy division, located in the Greater St. Louis Area. In this position, he worked on various projects in gene and cell therapy, contributing to the development and optimization of innovative therapeutic solutions. His experience at Pfizer allowed him to refine his scientific and regulatory skills in a commercial setting.
Academic Background and Postdoctoral Research
Emmanuel Adu Gyamfi completed his doctoral studies in Biochemistry and Molecular Virology at the University of Notre Dame, where he also served as a Research Assistant Graduate Student for five years and a Teaching Assistant for two years. He then undertook postdoctoral research at Northwestern University and Howard Hughes Medical Institute from 2013 to 2017, focusing on advanced scientific studies. Additionally, he spent a short period as a Visiting Research Graduate Student at UC Irvine in 2011.
Educational Achievements
Emmanuel Adu Gyamfi holds a Bachelor of Science degree in Biochemistry from the University of Ghana, and a Doctor of Philosophy in Biochemistry and Molecular Virology from the University of Notre Dame. He also earned a Certificate in Business for Scientists & Engineers from Northwestern University's Kellogg School of Management. This combination of scientific and business education provides him with a unique interdisciplinary perspective on regulatory strategies and scientific innovation.